TIP Company ImStem Biotechnology Doses First MS Patient in Clinical Trial

University of Connecticut

Nov 18, 2021

ImStem Biotechnology, a biopharmaceutical company in UConn's Technology Incubation Program (TIP), has dosed its first multiple sclerosis (MS) patient with its experimental stem cel…